Literature DB >> 12575242

[Value of simultaneous determination of serum hyaluronic acid, collagen type IV and the laminin level in diagnosing liver fibrosis].

Xiang-hui Liang1, Hui Zheng.   

Abstract

OBJECTIVE: To study the value of simultaneous determination of serum hyaluronic acid(HA), collagen Type IV (CIV) and the laminin (LN) level in the diagnosis of liver fibrosis.
METHODS: Serum HA, CIV and LN were measured by ELISA in 22 healthy persons, 10 cases of acute hepatitis, 10 cases of chronic hepatitis, 10 cases of heary chronic hepatitis, and another 25 cases of posthepatitic cirrhosis. The sensitivity, specificity and accuracy of simultaneous determination were compared with those of single determination in posthepatitic cirrhosis.
RESULTS: The levels of serum HA, CIV and LN in posthepatitic cirrhosis cases and heary chronic hepatitis cases were significantly higher than those in the other groups (P < 0.01). Simultaneous determination of these indices enhanced the diagnostic sensitivity, but decreased the diagnostic specificity.
CONCLUSION: Simultaneous determination of HA, CIV and LN can enhance the diagnostic sensitivity. Simultaneous determination of HA and CIV is an optimal choice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12575242

Source DB:  PubMed          Journal:  Hunan Yi Ke Da Xue Xue Bao        ISSN: 1000-5625


  3 in total

1.  Morphological and serum hyaluronic acid, laminin and type IV collagen changes in dimethylnitrosamine-induced hepatic fibrosis of rats.

Authors:  Chun-Hui Li; Dong-Ming Piao; Wen-Xie Xu; Zheng-Ri Yin; Jing-Shun Jin; Zhe-Shi Shen
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

2.  Preventive effect of Qianggan-Rongxian Decoction on rat liver fibrosis.

Authors:  Chun-Hui Li; Li-Hui Pan; Zong-Wei Yang; Chun-Yu Li; Wen-Xie Xu
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

3.  Serum hyaluronic acid as a noninvasive marker of hepatic fibrosis in chronic hepatitis B.

Authors:  Bita Geramizadeh; Katayoun Janfeshan; Mehdi Saberfiroozi
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.